Literature DB >> 24715546

From ischochymia to gastroparesis: proposed mechanisms and preferred management of dyspepsia over the centuries.

Klaus Bielefeldt1.   

Abstract

Dyspeptic symptoms are common with most patients suffering functional disorders that remain a therapeutic challenge for medical practitioners. Within the last three decades, gastric infection, altered motility, and hypersensitivity have gained and lost traction in explaining the development of functional dyspepsia. Considering these shifts, the aim of this review was to analyze changing understanding of and approaches to dyspepsia over a longer time period. Monographs, textbooks, and articles published during the last three centuries show that our understanding of normal gastric function has improved dramatically. With increased insight came new ideas about disease mechanisms, diagnostic options, and treatments. Despite shifts over time, the importance of functional abnormalities was recognized early on and explained in the context of societal influences and stressors, anxieties, and biological influences, thus resembling the contemporary biopsychosocial model of illness. Symptoms were often attributed to changes in secretion, motility, and sensation or perception with technological innovation often influencing proposed mechanisms and treatments. Many of the principles or even agents applied more than a century ago are still part of today's approach. This includes acid suppression, antiemetics, analgesics, and even non-pharmacologic therapies, such as gastric decompression or electrical stimulation of the stomach. This historical information does not only help us understand how we arrived at our current state of knowledge and standards of care, it also demonstrates that enthusiastic adoption of various competing explanatory models and the resulting treatments often did not survive the test of time. In view of the benign prognosis of dyspepsia, the data may function as a call for caution to avoid the potential harm of overly aggressive approaches or treatments with a high likelihood of adverse effects.

Entities:  

Mesh:

Year:  2014        PMID: 24715546     DOI: 10.1007/s10620-014-3144-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  116 in total

1.  Cyclic vomiting syndrome: a paroxismal disorder of brain-gut interaction.

Authors:  D R Fleisher
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997       Impact factor: 2.839

2.  Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

Authors:  P Moayyedi; R Feltbower; J Brown; S Mason; J Mason; J Nathan; I D Richards; A C Dowell; A T Axon
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

3.  Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial.

Authors:  V Meineche-Schmidt; E Christensen
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

4.  Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study.

Authors:  B Waldron; P T Cullen; R Kumar; D Smith; J Jankowski; D Hopwood; D Sutton; N Kennedy; F C Campbell
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

Review 5.  Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia.

Authors:  A P S Hungin; C Hill; A Raghunath
Journal:  Aliment Pharmacol Ther       Date:  2009-08-15       Impact factor: 8.171

6.  Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis.

Authors:  K L Jones; J M Wishart; M K Berry; J L Abitbol; M Horowitz
Journal:  Aliment Pharmacol Ther       Date:  2000-07       Impact factor: 8.171

Review 7.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

8.  Cellular changes in diabetic and idiopathic gastroparesis.

Authors:  Madhusudan Grover; Gianrico Farrugia; Matthew S Lurken; Cheryl E Bernard; Maria Simonetta Faussone-Pellegrini; Thomas C Smyrk; Henry P Parkman; Thomas L Abell; William J Snape; William L Hasler; Aynur Ünalp-Arida; Linda Nguyen; Kenneth L Koch; Jorges Calles; Linda Lee; James Tonascia; Frank A Hamilton; Pankaj J Pasricha
Journal:  Gastroenterology       Date:  2011-02-04       Impact factor: 22.682

Review 9.  Dyspepsia.

Authors:  Alexander C Ford; Paul Moayyedi
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287

10.  Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups.

Authors:  N J Talley; A L Weaver; A R Zinsmeister
Journal:  Am J Gastroenterol       Date:  1994-04       Impact factor: 10.864

View more
  4 in total

1.  Cerebral mechanism of puncturing at He-Mu point combination for functional dyspepsia: study protocol for a randomized controlled parallel trial.

Authors:  Shuai Yin; Yuan Chen; Du Lei; Rui-Rui Sun; Ting-Ting Ma; Pei-Min Feng; Zhao-Xuan He; Xue-Ling Suo; Pei-Hong Ma; Yu-Zhu Qu; Ke Qiu; Miao-Miao Jing; Qi-Yong Gong; Fan-Rong Liang; Jiao Chen; Fang Zeng
Journal:  Neural Regen Res       Date:  2017-05       Impact factor: 5.135

2.  From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.

Authors:  Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2017-06-02       Impact factor: 3.199

3.  Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment.

Authors:  Chun-Ling Zhang; Chang-Hui Geng; Zhi-Wei Yang; Yan-Lin Li; Li-Quan Tong; Ping Gao; Yue-Qiu Gao
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

Review 4.  Disorders of gastrointestinal hypomotility.

Authors:  Klaus Bielefeldt; Ashok Tuteja; Salman Nusrat
Journal:  F1000Res       Date:  2016-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.